These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 2909548

  • 41. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
    Vitti P, Chiovato L, Fiore E, Mammoli C, Rocchi R, Pinchera A.
    Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
    [Abstract] [Full Text] [Related]

  • 42. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
    Chen W, Man N, Li YS, Shan ZY, Teng WP.
    Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
    [Abstract] [Full Text] [Related]

  • 43. Simultaneous measurement of TSH-binding inhibitor immunoglobulin and thyroid stimulating autoantibody activities using cultured FRTL-5 cells in patients with untreated Graves' disease.
    Lu C, Kasagi K, Hidaka A, Hatabu H, Iida Y, Konishi J.
    Acta Endocrinol (Copenh); 1990 Sep; 123(3):282-90. PubMed ID: 1978457
    [Abstract] [Full Text] [Related]

  • 44. Clinical significance of elevated labeled TSH binding (LTB) activity in sera of patients with Graves' disease and other thyroid disorders.
    Akamizu T, Mori T, Ishii H, Yokota T, Nakamura H, Imura H.
    J Endocrinol Invest; 1987 Oct; 10(5):459-64. PubMed ID: 2892876
    [Abstract] [Full Text] [Related]

  • 45. Evaluation of serum basal thyrotrophin levels and thyrotrophin receptor antibody activities as prognostic markers for discontinuation of antithyroid drug treatment in patients with Graves' disease.
    Cho BY, Shong MH, Yi KH, Lee HK, Koh CS, Min HK.
    Clin Endocrinol (Oxf); 1992 Jun; 36(6):585-90. PubMed ID: 1358483
    [Abstract] [Full Text] [Related]

  • 46. Rabbits immunized with thyroid-stimulating hormone produce autoantiidiotypic thyroid-stimulating antibodies.
    Beall GN, Rapoport B, Chopra IJ, Kruger SR.
    J Clin Invest; 1985 May; 75(5):1435-40. PubMed ID: 2860123
    [Abstract] [Full Text] [Related]

  • 47. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M, Koizumi Y, Aizawa T, Yamada T, Takahashi Y, Watanabe T, Kamoi K.
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [Abstract] [Full Text] [Related]

  • 48. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.
    Baker JR, Lukes YG, Smallridge RC, Berger M, Burman KD.
    J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. An anti-idiotypic antibody against Graves' IgG.
    Hawe BS, Davies TF, Farid NR.
    Immunol Lett; 1987 Jun; 15(2):95-100. PubMed ID: 2442098
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Measurement of thyroid-stimulating immunoglobulins by incorporation of tritiated-adenine into intact FRTL-5 cells: a viable alternative to radioimmunoassay for the measurement of cAMP.
    Leedman PJ, Frauman AG, Colman PG, Michelangeli VP.
    Clin Endocrinol (Oxf); 1992 Dec; 37(6):493-9. PubMed ID: 1363083
    [Abstract] [Full Text] [Related]

  • 53. Thyroid peroxidase activity-inhibiting immunoglobulins in patients with autoimmune thyroid disease.
    Okamoto Y, Hamada N, Saito H, Ohno M, Noh J, Ito K, Morii H.
    J Clin Endocrinol Metab; 1989 Apr; 68(4):730-4. PubMed ID: 2921308
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Thyroid response, especially to thyrotropin-binding inhibitory immunoglobulins, in euthyroid relatives of patients with Graves' disease: a clinical follow-up.
    Tamai H, Kasagi K, Morita T, Hidaka A, Kuma K, Konishi J, Kumagai LF, Nagataki S.
    J Clin Endocrinol Metab; 1990 Jul; 71(1):210-5. PubMed ID: 1973421
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment.
    Tamai H, Hirota Y, Kasagi K, Matsubayashi S, Kuma K, Iida Y, Konishi J, Okimura MC, Walter RM, Kumagai LF.
    J Clin Endocrinol Metab; 1987 Apr; 64(4):718-22. PubMed ID: 2434520
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.